-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Akari Therapeutics Plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
- Akari Therapeutics Plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $13K, a 1200% increase year-over-year.
- Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2023 was $4K, unchanged from 2022.
- Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2022 was $4K, a 3.05% decline from 2021.
- Akari Therapeutics Plc annual Depreciation, Depletion and Amortization for 2021 was $4.13K, a 53.7% decline from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)